Antimetastatic and antitumor activities of interleukin 10 in transfected human prostate PC-3 ML clones: Orthotopic growth in severe combined immunodeficient mice

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2257-2263

  Stearns, Mark E ^a   Wang, Min ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; GENETIC TRANSFECTION; IMMUNE DEFICIENCY; METASTASIS; METASTASIS INHIBITION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL CLONE; CELL CULTURE; CELL DIVISION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIVISION; CLONE CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-10; MALE; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031594892     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., and Mosman, T. R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science (Washington DC), 248: 1230-1234, 1990.
2. Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., and Romagnani, S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol., 150: 353-360, 1993.
3. Howard, M., O'Garra, A., Ishida, H., de Waal Malefyt, R., and de Vries, J. Biological properties of interleukin 10. J. Clin. Immunol., 12: 239-247, 1992.
4. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., and O'Garra, A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol., 147: 3815-3822, 1991.
5. Bogdan, C., Vodovotz, Y., and Nathan, C. Macrophage deactivation by interleukin 10. J. Exp. Med., 174: 1549-1555, 1991.
6. Oswald, I. P., Gazzinelli, R. T., Sher, A., and James, S. L. IL-10 synergizes with Il-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J. Immunol., 148: 3578-3582, 1992.
7. Cenci, E., Romani, L., Menacci, A., Spaccapelo, R., Schiafella, E., Puccetti, P., and Bistoni, F. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur. J. Immunol., 23: 1034-1038, 1993.
8. Ralph, P., Nakoniz, I., Sampson-Johannes, A., Fong, S., Lowe, D., Min, H. Y., and Lin, L. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J. Immunol., 148: 808-814, 1992.
9. de Waal Malefyt, R., Abrams, J., Bennet, B., Figdor, C. G., and de Vries, J. E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med., 174: 1209-1220, 1991.
10. Te Velde, A. A., de Waal Malefyt, R., Huijbens, R. J. F., de Vries, J. E., and Figdor, C. G. IL-10 stimulates monocyte FcγR surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-γ, IL-4, and IL-10. J. Immunol., 149: 4048-4052, 1992.
11. Huang, S., Xie, K., Bucana, C. D., Ullrich, S. E., and Bar-Eli, M. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Clin. Cancer Res., 2: 1969-1979, 1996.
12. Kundu, N., Beaty, T. L., Jackson, M. J., and Fulton, A. M. Anti-metastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. J. Natl. Cancer Inst., 88: 536-541, 1996.
13. Richter, G., Kruger-Krasagakes, S., Hein, G., Huls, C., Schmitt, E., Diamantstein, T., and Blankenstein, T. Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res., 53: 4134-4137, 1993.
14. Sato, T., McCue, P., Masuoka, K., Salwen, S., Lattime, E. D., Mastrangelo, M. J., and Berd, D. Interleukin 10 production by human melanoma. Clin. Cancer Res., 2: 1383-1390, 1996.
15. Nabioullin, R., Sone, S., Mizuno, K., Yano, S., Nishioka, Y., Haku, T., and Ogura, T. Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages. J. Leukocyte Biol., 55: 437-442,1994.
16. Wang M., and Stearns, M. E. Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in s.c.i.d. mice. Differentiation, 48: 115-125, 1991.
17. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
18. Dellabona, P., Casorati, G., Friedli, B., Angman, L., Sallusto, F., Tunnacliffe, A., Roosneck, E., and Lanzavecchi, A. In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor α/β CD4-8-subset. J. Exp. Med., 177: 1763-1771, 1993.
19. Tepper, R. I., and Mule, J. J. Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Trier., 5: 153-164, 1994.
20. Giovarelli, M., Musiani, P., Modesti, A., Dellabona, P., Casorati, G., Allione, A., Consalvo, M., Cavallo, F., di Pierro, F., De Giovanni, C., Musso, T., and Forni, G. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J. Immunol., 155: 3112-3123, 1995.
21. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
22. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchel, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47: 936-942, 1987.
23. Ho, A. S. Y., Liu, Y., Khan, T. A., Hsu, D-H., Bazan, J. F., and Moore, K. W. A receptor for interleukin 10 is related to interferon receptors. Proc. Natl. Acad. Sci. USA, 90: 11267-11271, 1993.
24. Stearns, M., Wang, M., and Stearns, M. E. Cytokine (IL-10, IL-6) induction of tissue inhibitor of metalloproteinase 1 in primary human prostate tumor cell lines. Oncol. Res., 7: 173-181, 1995.
25. Greene, G. F., Kitadai, Y., Pettaway, C. A., von Eschenbach, A. C., Bucana, C. D., and Fidler, I. J. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol., 150: 1571-1582, 1997.
26. Fudge, K., Wang, C. Y., and Stearns, M. E. Immunohistochemistry analysis of PDGF A/B chains and PDGF alpha and beta receptor expression in BPH and Gleason graded human prostate adenocarcinomas. Mod. Pathol., 7: 549-554, 1994.
27. Im, S-Y., Ko, H-M., Han, S-J., Choi, J-H., Park, C-S., Lee, H-K., and Lee, D-G. Prevention of tumor growth and metastasis by interleukin (IL)-10 transfection: a potent inhibitory role of IL-10 on angiogenesis. Mol. Cells, 6: 473-480, 1996.
28. Bogdon, C., Vodovotz, Y., and Nathan, C. Macrophage deactivation by interleukin 10. J. Exp. Med., 174: 1549-1555, 1991.
29. Gazzinelli, R. T., Oswald, I. P., James, S. L., and Sher, A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J. Immunol., 148: 1792-1796, 1992.
30. Ralph, P., Nakoinz, A. J., Sampson, J. A., Fong, S., Lowe, D., Min, H. Y., and Lin, L. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J. Immunol., 148: 808-814, 1992.
31. Steams, M. E., Fudge, K. Garcia, F., and Wang, M. Interleukin 10 inhibition of human prostate PC-3 ML cell metastases in SCID mice. IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-9 expression. Inv. Metastasis, 17: 62-74, 1997.
32. Gimbrone, M. A. Jr., Leapman, S. B., Cotran, R. S., and Folkman, J. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med., 136: 261-276, 1972.
33. Gimbrone, M. A. Jr., Cotran, R. S., Leapman, S. B., and Folkman, J. Tumor growth and neovascularization: an experimental model using the rabbit cornea. J. Natl. Cancer Inst., 52: 413, 1974.
34. Evans, R. The effect of azathioprine on host cell infiltration and growth of a murine fibrosarcoma. Int. J. Cancer, 20: 120, 1977.
35. Evans, R. Effect of x-irradiation on host-cell infiltration and growth of a murine fibrosarcoma. Br. J. Cancer, 35: 557, 1977.
36. Wang M., Hu, Y., Shima, I., and Stearns, M. E. Identification of positive and negative regulator elements for the tissue inhibitor of metalloproteinase 1 gene. Oncol. Res., in press, 1998.
37. Reitamo, S., Remitz, A., Tamai, K., Ledo, I., and Uitto, J. Interleukin 10 up-regulates elastin gene expression in vivo and in vitro at the transcriptional level. Biochem. J., 302: 331-333, 1994.
38. Liu, A., and Stearns, M. E. Role of follistatin in tumor cell growth and human prostate cancer progression. Front. Biosci. (Washington DC), in press, 1998.
39. Chernoff, A. E., Granowitz, E. V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Wolff, S. M., and Dinarello, C. A. A randomized, controlled trial of IL-10 in humans Inhibition of inflammatory cytokine production and immune response. J. Immunol., 154: 5492-5499, 1995.